Rankings
▼
Calendar
DBVT Q4 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena
DBVT
DBV Technologies S.A.
$560M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+341.9% YoY
Gross Profit
$3M
100.0% margin
Operating Income
-$13M
-459.7% margin
Net Income
-$14M
-466.3% margin
EPS (Diluted)
$-1.25
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$15M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$147M
Total Liabilities
$47M
Stockholders' Equity
$99M
Cash & Equivalents
$77M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
-$1M
+341.9%
Gross Profit
$3M
-$1M
+341.9%
Operating Income
-$13M
-$40M
+66.4%
Net Income
-$14M
-$39M
+65.4%
← FY 2021
All Quarters
Q1 2022 →